These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12590895)

  • 1. A new era in the treatment of coronary disease?
    Morice MC
    Eur Heart J; 2003 Feb; 24(3):209-11. PubMed ID: 12590895
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug eluting coronary stents.
    Jenkins NP; Prendergast BD; Thomas M
    BMJ; 2002 Dec; 325(7376):1315-6. PubMed ID: 12468460
    [No Abstract]   [Full Text] [Related]  

  • 3. Polymer-sirolimus-eluting stents in de novo lesions.
    Schuler G
    Herz; 2004 Mar; 29(2):152-61. PubMed ID: 15057437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economics of sirolimus-eluting stents: drug-eluting stents have really arrived.
    Weintraub WS
    Circulation; 2004 Aug; 110(5):472-4. PubMed ID: 15289386
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug-eluting stents: the panacea for restenosis?
    Lim MC
    Singapore Med J; 2004 Jul; 45(7):300-2. PubMed ID: 15221043
    [No Abstract]   [Full Text] [Related]  

  • 6. [Safety and current indications during "real life" use of sirolimus-eluting coronary stents in Germany. Results from the prospective multicenter German Cypher Registry].
    Zahn R; Hamm CW; Zeymer U; Schneider S; Nienaber CA; Richardt G; Kelm M; Levenson B; Bonzel T; Tebbe U; Schöbel WA; Sabin G; Senges J;
    Herz; 2004 Mar; 29(2):181-6. PubMed ID: 15057439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapamycin analogs for stent-based local drug delivery. Everolimus- and tacrolimus-eluting stents.
    Grube E; Buellesfeld L
    Herz; 2004 Mar; 29(2):162-6. PubMed ID: 15054588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sirolimus-eluting coronary stent.
    Vishnevetsky D; Patel P; Tijerino H; Gandhi PJ
    Am J Health Syst Pharm; 2004 Mar; 61(5):449-56. PubMed ID: 15018222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug-eluting stents: do they keep their promises?].
    Nordmann A
    Praxis (Bern 1994); 2006 Apr; 95(15):581-3. PubMed ID: 16640178
    [No Abstract]   [Full Text] [Related]  

  • 10. How many grails do we need?
    Holmes DR
    Circulation; 2004 May; 109(18):2158-9. PubMed ID: 15136508
    [No Abstract]   [Full Text] [Related]  

  • 11. A meta-analysis of clinical trials of paclitaxel- and sirolimus-eluting stents in patients with obstructive coronary artery disease.
    Shafiq N; Malhotra S; Pandhi P; Grover A; Uboweja A
    Br J Clin Pharmacol; 2005 Jan; 59(1):94-101. PubMed ID: 15606446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-eluting stents for in-stent restenosis and acute myocardial infarction: present data from nonrandomized studies.
    Schofer J; Bode C; Silber S
    Herz; 2004 Mar; 29(2):195-200. PubMed ID: 15057441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sirolimus-eluting vs paclitaxel-eluting stents -- the trials confirm differences in clinical outcome].
    Gil RJ
    Kardiol Pol; 2005 Nov; 63(5):574-6; discussion 577. PubMed ID: 16362868
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug eluting stents: an updated meta-analysis of randomised controlled trials.
    Roiron C; Sanchez P; Bouzamondo A; Lechat P; Montalescot G
    Heart; 2006 May; 92(5):641-9. PubMed ID: 16216853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Do drug-eluting stents influence the spectrum of coronary artery bypass surgery?].
    Matschke K; Tugtekin SM; Kappert U; Jung F; Park JW; Knaut M
    Herz; 2004 Mar; 29(2):201-7. PubMed ID: 15057442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The "0%" restenosis study.
    Colombo A
    Ital Heart J; 2002 Oct; 3(10):559-6. PubMed ID: 12478812
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug-eluting stents: from randomized trials to the real world.
    Saia F; Degertekin M; Lemos PA; Serruys PW
    Minerva Cardioangiol; 2004 Oct; 52(5):349-63. PubMed ID: 15514571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A paclitaxel coated stent used for in-stent restenosis within a sirolimus coated stent fails to protect against recurrent restenosis.
    Bainbridge AD; Muir D; Fath-Ordoubadi F
    Heart; 2005 Jun; 91(6):730. PubMed ID: 15894762
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of drug eluting stents in patients with and without diabetes mellitus: indirect comparison of controlled trials.
    Stettler C; Allemann S; Egger M; Windecker S; Meier B; Diem P
    Heart; 2006 May; 92(5):650-7. PubMed ID: 16251229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-eluting stents: new era and new concerns.
    Bhatia V; Bhatia R; Dhindsa M
    Postgrad Med J; 2004 Jan; 80(939):13-8. PubMed ID: 14760171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.